Re-sensitization of immune checkpoint therapy resistant cancers to cytotoxic T-lymphocyte mediated killing
Re-sensitization of immune checkpoint therapy resistant cancers to cytotoxic T-lymphocyte mediated killing
免疫检查点疗法耐药性癌症对细胞毒性 T 淋巴细胞介导的杀伤重新敏感
批准号：
412967
负责人：
Caumanns Joseph J
金额：
$9.83万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-10-01 至 2022-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cytotoxic T-lymphocytes have a key role in elimination of cancer cells by the immune system, but their anti-cancer efficacy is severely hampered by immune checkpoints. Immune checkpoint inhibition (ICI) can re-activate anti-cancer immunity and provides du
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
